ETHOSS A SYNTHETIC BONE GRAFT

Description

EthOss Synthetic Bone Graft is a fully synthetic, resorbable bone grafting material developed for predictable bone regeneration in dental implantology and oral surgery. It is composed of 65% β-Tricalcium Phosphate (β-TCP) and 35% Calcium Sulphate, combining an osteoconductive scaffold with a material that sets and stabilizes the grafted area.

The β-TCP component provides a scaffold that supports new bone formation, while calcium sulphate helps stabilize the graft and provides a temporary barrier during the initial healing period. EthOss gradually resorbs as the healing process progresses and is designed to support replacement by newly formed bone.

Its fully synthetic composition eliminates the need for human- or animal-derived graft material, making it suitable for clinicians looking for a synthetic approach to bone augmentation and regenerative procedures.

KEY FEATURES

• 100% Synthetic Bone Graft: Manufactured without human- or animal-derived graft material.
• Dual-Component Formulation: Contains 65% β-TCP and 35% Calcium Sulphate.
• Supports Bone Regeneration: β-TCP provides an osteoconductive scaffold for new bone formation.
• Resorbable Material: Designed to gradually resorb during the bone-healing process.
• In-Situ Setting: Sets within the grafted area to provide stability during early healing.
• Temporary Barrier Function: Calcium sulphate provides a temporary barrier over the graft during the initial healing phase.
• Stable Graft Placement: Helps maintain the graft material at the treatment site.
• Convenient Handling: Syringe-based presentation allows controlled preparation and placement.
• Versatile Clinical Application: Suitable for various dental bone augmentation and regenerative procedures.

Key Specifications

EthOss Synthetic Bone Graft is a 100% synthetic, resorbable bone grafting material composed of 65% β-Tricalcium Phosphate (β-TCP) and 35% Calcium Sulphate. The β-TCP component acts as an osteoconductive scaffold to support new bone formation, while the calcium sulphate component assists in graft stabilization and provides a temporary barrier during the initial healing phase. EthOss is designed to set in situ after placement and gradually resorb as the bone regeneration process progresses. It contains no human- or animal-derived graft material and is supplied in a convenient syringe-based delivery system for controlled preparation and placement. It is intended for dental bone regeneration and augmentation procedures, including applications in implantology and oral surgery.

Packaging

1 box contain 3 syringe